Common GLP-1 Myths, Cleared Up?

The rumours travel faster than the facts. Here are the misunderstandings we hear most in the UK, set straight.

Key takeaways

• They aren't 'fat burners' or stimulants.
• They aren't insulin.
• Ozempic and Wegovy are the same drug with different licences.
• They aren't a quick course — for many they're long-term.

Because GLP-1 medicines are everywhere in the news, the myths have multiplied. Here's the reality — usually calmer, and more reassuring, than the rumour.

It's easy to see how the confusion spreads. A friend mentions something, a headline simplifies it, and a half-remembered fact starts to feel like common knowledge. The trouble is that these particular misunderstandings can leave people either expecting too much or worrying needlessly. So let's take the ones we hear most often, one at a time.

Myth: they 'melt fat'

This is probably the most common image — a medicine that somehow dissolves fat away. It doesn't work like that at all. GLP-1 medicines don't act on your fat tissue directly. Instead they copy a hormone involved in appetite and blood sugar, so you tend to feel satisfied with less and think about food less. Any weight change follows from eating differently, not from the medicine attacking fat.

Why does this matter to you? Because it sets a realistic expectation. The change tends to be gradual and works hand in hand with everyday habits — it isn't an overnight transformation, and it isn't magic.

Myth: they're the same as insulin

They're not insulin, and this is an important distinction. GLP-1 medicines help your body release its own insulin at the right moments — chiefly when blood sugar rises after a meal — among other effects, rather than being insulin themselves. Because they nudge a natural process rather than replacing it, used on their own they're far less likely to cause the low blood sugar that injected insulin can.

Myth: 'Ozempic' is the weight-loss one

People blur the names constantly, and it's understandable. Ozempic is licensed in the UK for type 2 diabetes; Wegovy is the weight-management licence for the very same active drug, semaglutide. So when someone says they're on 'the Ozempic for weight loss', they usually mean a semaglutide product prescribed for that purpose. For the full story of why one molecule carries two names, see Ozempic vs Wegovy.

Myth: a few months and you're done

Many people assume these are a short course, like a week of antibiotics. For most people, though, appetite and weight tend to drift back if the medicine stops — which is why clinicians often treat them as long-term tools rather than a quick fix.

That's not a disappointment so much as a reframing: type 2 diabetes and obesity are long-term conditions, and like blood-pressure medicines, GLP-1s tend to keep working while you keep taking them. There's more on this in our piece on stopping.

Myth: you can buy them over the counter

In the UK these are prescription-only medicines, or POMs. A qualified prescriber must assess you first — you can't simply pick them up from a pharmacy shelf, and they aren't sold without that check.

Myth: they're a shortcut that skips healthy habits

Some people worry the opposite way — that taking a medicine means 'cheating' or giving up on effort. In practice it's the reverse. By quietening the constant pull of appetite, these medicines tend to make sensible eating and activity feel achievable rather than like a daily battle of willpower. They're designed to work alongside those habits, not instead of them.

Myth: side effects mean something is wrong

Early tummy effects like mild nausea worry people, but they're usually just the body settling in, and they tend to ease over the first few weeks. That said, anything severe or persistent is always worth raising with a clinician — knowing the difference is part of feeling at ease.

The thread Not a gimmick, not a miracle — a genuinely useful medicine for the right people, used with proper guidance. When something sounds too dramatic in either direction, it's usually worth a second look.

Sources

• MHRA
• NICE
• NHS
• manufacturer prescribing information